Clinicopathologic factors of the recurrent tumor predict outcome in patients with ipsilateral breast tumor recurrence

Cancer

Volumn 117, Issue 10, 2011, Pages 2035-2043

  Panet Raymond, Valerie ^a   Truong, Pauline T ^b,c   Alexander, Cheryl ^b   Lesperance, Mary ^d   McDonald, Rachel E ^b   Watson, Peter H ^b,c  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF VICTORIA   (Canada)

Author keywords

high grade; ipsilateral breast tumor recurrence; lymphovascular invasion; survival; time to recurrence

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER HORMONE THERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASTECTOMY; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; RECURRENCE; RISK;

EID: 79955505283     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25767     Document Type: Article

References (39)

1. Jacobson JA, Danforth DN, Cowan KH, et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med. 1995; 332: 907-911.
2. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002; 347: 1227-1232. (Pubitemid 35176241)
3. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002; 347: 1233-1241. (Pubitemid 35176242)
4. Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM,. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1995; 333: 1456-1461.
5. Arriagada R, Le MG, Rochard F, Contesso G,. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol. 1996; 14: 1558-1564. (Pubitemid 26134214)
6. Clark RM, Whelan T, Levine M, et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst. 1996; 88: 1659-1664. (Pubitemid 26384812)
7. Fowble B, Solin LJ, Schultz DJ, Rubenstein J, Goodman RL,. Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment. Int J Radiat Oncol Biol Phys. 1990; 19: 833-842. (Pubitemid 20345149)
8. Kurtz JM, Amalric R, Brandone H, et al. Local recurrence after breast-conserving surgery and radiotherapy. Frequency, time course, and prognosis. Cancer. 1989; 63: 1912-1917. (Pubitemid 19118888)
9. Liljegren G, Holmberg L, Bergh J, et al. 10-year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol. 1999; 17: 2326-2333. (Pubitemid 29368230)
10. Poggi MM, Danforth DN, Sciuto LC, et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer. 2003; 98: 697-702. (Pubitemid 36959264)
11. Whelan T, Clark R, Roberts R, Levine M, Foster G,. Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality: results from a randomized trial. Investigators of the Ontario Clinical Oncology Group. Int J Radiat Oncol Biol Phys. 1994; 30: 11-16. (Pubitemid 24291108)
12. Fisher B, Anderson S, Fisher ER, et al. Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet. 1991; 338: 327-331.
13. Veronesi U, Marubini E, Del Vecchio M, et al. Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst. 1995; 87: 19-27.
14. Wapnir IL, Anderson SJ, Mamounas EP, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in 5 National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J Clin Oncol. 2006; 24: 2028-2037. (Pubitemid 46622111)
15. Anderson SJ, Wapnir I, Dignam JJ, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in 5 National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer. J Clin Oncol. 2009; 27: 2466-2473.
16. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 366: 2087-2106. (Pubitemid 41797643)
17. Alpert TE, Kuerer HM, Arthur DW, Lannin DR, Haffty BG,. Ipsilateral breast tumor recurrence after breast conservation therapy: outcomes of salvage mastectomy vs. salvage breast-conserving surgery and prognostic factors for salvage breast preservation. Int J Radiat Oncol Biol Phys. 2005; 63: 845-851. (Pubitemid 41400074)
18. della Rovere GQ, Benson JR,. Ipsilateral local recurrence of breast cancer: determinant or indicator of poor prognosis? Lancet Oncol. 2002; 3: 183-187.
19. Koscielny S, Tubiana M,. Link between local recurrence and distant metastases in human breast cancer. Int J Radiat Oncol Biol Phys. 1999; 45: 245-246.
20. McGrath S, Antonucci J, Goldstein N, et al. Long-term patterns of in-breast failure in patients with early stage breast cancer treated with breast-conserving therapy: a molecular based clonality evaluation. Am J Clin Oncol. 2010; 33: 17-22.
21. Gentilini O, Botteri E, Rotmensz N, et al. When can a second conservative approach be considered for ipsilateral breast tumour recurrence? Ann Oncol. 2007; 18: 468-472. (Pubitemid 46359624)
22. Greene FL, Page DL, Fleming ID,. American Joint Committee on Cancer Staging Manual. 6th ed. New York, NY: Springer; 2002.
23. Sobin LH, Wittekind CH, eds. TNM Classification of Malignant Tumors. 5th ed. New York, NY: John Wiley & Sons; 1997.
24. Megha T, Neri A, Malagnino V, et al. Traditional and new prognosticators in breast cancer: Nottingham index, Mib-1 and estrogen receptor signaling remain the best predictors of relapse and survival in a series of 289 cases. Cancer Biol Ther. [published online ahead of print February 16, 2010.]
25. Beinart G, Gonzalez-Angulo AM, Broglio K, et al. Clinical course of 771 patients with bilateral breast cancer: characteristics associated with overall and recurrence-free survival. Clin Breast Cancer. 2007; 7: 867-874.
26. Hanrahan EO, Valero V, Gonzalez-Angulo AM, Hortobagyi GN,. Prognosis and management of patients with node-negative invasive breast carcinoma that is 1 cm or smaller in size (stage 1; T1a,bN0M0): a review of the literature. J Clin Oncol. 2006; 24: 2113-2122. (Pubitemid 46628472)
27. Chia SK, Speers CH, Bryce CJ, Hayes MM, Olivotto IA,. Ten-year outcomes in a population-based cohort of node-negative, lymphatic, and vascular invasion-negative early breast cancers without adjuvant systemic therapies. J Clin Oncol. 2004; 22: 1630-1637. (Pubitemid 41079801)
28. Voogd AC, Nielsen M, Peterse JL, et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of 2 large European randomized trials. J Clin Oncol. 2001; 19: 1688-1697. (Pubitemid 32230869)
29. Fourquet A, Campana F, Zafrani B, et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. Int J Radiat Oncol Biol Phys. 1989; 17: 719-725. (Pubitemid 19250523)
30. van Tienhoven G, Voogd AC, Peterse JL, et al. Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in 2 randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group. Eur J Cancer. 1999; 35: 32-38. (Pubitemid 29079488)
31. Haffty BG, Fischer D, Beinfield M, McKhann C,. Prognosis following local recurrence in the conservatively treated breast cancer patient. Int J Radiat Oncol Biol Phys. 1991; 21: 293-298.
32. Moran MS, Haffty BG,. Local-regional breast cancer recurrence: prognostic groups based on patterns of failure. Breast J. 2002; 8: 81-87. (Pubitemid 34233585)
33. Radiation Therapy Oncology Group. Summaries-breast. Available at: Accessed October 3, 2010.
34. Galper S, Blood E, Gelman R, et al. Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2005; 61: 348-357. (Pubitemid 40164426)
35. Shen J, Hunt KK, Mirza NQ, et al. Predictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrence. Cancer. 2005; 104: 479-490. (Pubitemid 41022803)
36. Schmoor C, Sauerbrei W, Bastert G, Schumacher M,. Role of isolated locoregional recurrence of breast cancer: results of 4 prospective studies. J Clin Oncol. 2000; 18: 1696-1708. (Pubitemid 30220548)
37. Parikh RR, Housman D, Yang Q, Toppmeyer D, Wilson LD, Haffty BG,. Prognostic value of triple-negative phenotype at the time of locally recurrent, conservatively treated breast cancer. Int J Radiat Oncol Biol Phys. 2008; 72: 1056-1063.
38. Berry DA, Cirrincione C, Henderson IC, et al. Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer. JAMA. 2006; 295: 1658-1667.
39. Wapnir IL, Aebi S, Geyer CE, et al. A randomized clinical trial of adjuvant chemotherapy for radically resected locoregional relapse of breast cancer: IBCSG 27-02, BIG 1-02, and NSABP B-37. Clin Breast Cancer. 2008; 8: 287-292. (Pubitemid 351962153)